Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA).
Saved in:
| Title: | Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA). |
|---|---|
| Authors: | Karamanos B; Diabetes Center, 2nd Department of Internal Medicine and Research Laboratory, National University of Athens, Hippokration General Hospital, Athens, Greece. diavitologiko1@hippocratio.gr, Thanopoulou A, Drossinos V, Charalampidou E, Sourmeli S, Archimandritis A |
| Corporate Authors: | Hellenic ECLA Study Group |
| Source: | Current medical research and opinion [Curr Med Res Opin] 2011 Feb; Vol. 27 (2), pp. 303-13. Date of Electronic Publication: 2010 Dec 09. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
